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ABSTRACT. Objective. To investigate the patterns of tumor necrosis factor-a (TNF-a), interleukin-1b (IL-1b),
IL-6, interferon-c (IFN-c) and interleukin-1 receptor antagonist (IL-1Ra) during the course of dengue shock
syndrome.
Design. Prospective clinical study.
Setting. Pediatric Intensive Care Unit, Dr. Kariadi Hospital, the university hospital of Diponegoro University,
Semarang, Indonesia.
Patients. Fifty children with dengue shock syndrome.
Measurements. The plasma concentration and the ex vivo production, with and without lipopolysaccharide (LPS),
of TNF-a, IL-1b and IL-1Ra were measured in duplicate by nonequilibrium radioimmunoassay (RIA); IFN-c and
IL-6 were measured by ELISA.
Results. During the acute phase, the plasma concentrations and the ex vivo production without LPS of IL-1Ra
were considerably elevated and returned to normal on recovery. However, the ex vivo LPS-stimulated production
of the proinflammatory cytokines TNF-a and IL-1b were considerably depressed. Also, these concentrations
returned towards normal on recovery. In non-survivors, the plasma concentrations of IL-6 and IL-1Ra were
significantly higher than in survivors (p < 0.00001 and p = 0.0005, respectively). In addition, the ex vivo production
of IL-1Ra in non-survivors was significantly higher than in survivors, both without LPS stimulation (p = 0.0008)
and with LPS (p < 0.004). IL-1Ra was significantly associated with mortality (p = 0.007).
Conclusion. Since IL-1Ra was significantly associated with mortality, this measurement may be used as an index
of disease severity in dengue shock syndrome.
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INTRODUCTION
Dengue virus infection is caused by any of four serotypes
of the virus (DEN-1, DEN-2, DEN-3, and DEN-4). The
disease may manifest itself as a dengue fever (DF), char-
acterized by sudden onset of fever and a variety of nonspe-
cific signs and symptoms, including headache, joint and
muscle pains, retro-orbital pain, rash and bleeding mani-
festations [1, 2], or as dengue hemorrhagic fever (DHF),
the severe form of the disease. Patients with DHF, almost
exclusively children, develop thrombocytopenia, hemor-
rhage and increased capillary permeability resulting in
plasma leakage. DHF may develop into dengue shock
syndrome (DSS), the most severe form of DHF, with signs
of circulatory failure, including narrow pulse pressure
(20 mm Hg), hypotension, or frank shock [1]. Plasma
leakage and bleeding are the two major pathophysiological
changes in DHF/DSS that determine the severity of the
disease. The pathogenetic mechanisms responsible for the
increased permeability of vascular endothelial cells in
DHF have not been elucidated, however, it has been sug-
gested that cytokines and other mediators, which are re-
leased during the immune response to dengue virus infec-
tion, may form the underlying mechanism [3]. It is
hypothesized that in secondary infections with a virus of a
different serotype from the one that caused the primary
infection, cross-reactive antibodies enhance the infection
by and replication of dengue virus in mononuclear phago-
cytic cells [4, 5]. In addition, these cells produce and
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secrete pro-inflammatory cytokines, including tumor ne-
crosis factor-a (TNF-a), interleukin-1 b (IL-1b), and IL-6
[6-8], as well as antiinflammatory mediators, the soluble
TNF-receptor p55 (sTNFRp55), sTNFRp75 and IL-1 re-
ceptor antagonist (sIL-1Ra) [9]. CD4+T lymphocytes are
activated and produce a number of cytokines including
gamma interferon (IFN-c), IL-2, IL-4, IL-5 and IL-10 [10-
12]. Previous studies have reported a relationship between
high levels of TNF-a, IL-6 and disease severity [6-8]. In
addition, the role of TNF-a in plasma leakage has been
demonstrated indirectly by the correlation of soluble tu-
mor necrosis factor receptors (sTNFRs) with the degree of
subsequent pleural effusion [13]; and, the role of cytokines
in the initiation of coagulation and fibrinolysis has been
studied intensively in Gram negative-sepsis and endotox-
aemia [14].
We performed a prospective clinical study in children with
DSS to investigate the patterns of TNF-a, IL-1b, IL-6,
IFN-c and IL-1Ra during the course of the disease, and to
identify which of these cytokines were related to mortality.
PATIENTS AND METHODS
Study setting
This prospective study was performed at the Dr. Kariadi
Hospital, the university hospital of Diponegoro University,
Semarang, Indonesia. The research protocol in this study
was reviewed and approved by the institutional Review
Board of the Dr. Kariadi Hospital/Diponegoro University.
Written informed consent was obtained from the chil-
dren’s parents or legal guardians.
Patients
Between June and November 1996, during an outbreak of
dengue in Indonesia, 50 consecutive children with the
clinical diagnosis of DSS and admitted to the Paediatric
Intensive Care Unit were enrolled in the study. The diag-
nosis of DSS (DHF grade III and grade IV) was finally
based on the 1997 WHO case definition [1], consisting of
four criteria for DHF, plus evidence of circulatory failure.
The criteria for DHF consisted of: (i) fever, or history of
acute fever, lasting 2-7 days (ii) hemorrhagic tendencies
including petechiae, ecchymoses, purpura, epistaxis, he-
matemesis, melena (iii) thrombocytopenia, 100.000 cells
per mm3 or less (iv) evidence of plasma leakage due to
increased vascular permeability, manifested by at least one
of the following: a rise in the hematocrit equal to or greater
than 20%; a drop in the hematocrit following volume-
replacement equal to or greater than 20% of baseline; signs
of plasma leakage such as pleural effusion, ascites and
hypoproteinemia; evidence of circulatory failure mani-
fested by: rapid and weak pulse; narrow pulse pressure
(20 mmHg); hypotension; cold, clammy skin and restless-
ness. Only children > 3 years old were allowed for blood-
sampling.
Patient monitoring
Thorough clinical assesment using a medical record form
was performed daily from the day of admission to the
Intensive Care Unit until discharge from that Unit or death.
Laboratory tests to support clinical management included
blood cell counts, tests for hemostasis (prothrombin time
and activated partial thromboplastin time), as well as bio-
chemical tests for kidney and liver functions and electro-
lytes status. Also, chest x-ray and ECG were done rou-
tinely.
Specimen collection and whole blood culture
Blood specimens were collected in vacutainer tubes (Bec-
ton Dickinson, Rutherford, NJ 07417, USA). Specimens
for cytokine assays were collected in the acute phase of the
disease (on the day of admission: day 0, on day 1 and 2),
and on day 7 or the day of discharge if the patient was
hospitalized for less than 7 days. Three, 4 ml samples of
blood were collected into sterile tubes containing EDTA,
from each patient. To each tube 125 µL aprotinin (Trasylol,
Bayer, Leverkusen, Germany; final concentration 625 kal-
likreine inactivating units/mL) were added through the
stopper by a tuberculin needle and syringe. One tube was
centrifuged directly at 1,250 g for 10 minutes, and there-
after at 15,000 g for one minute to remove platelets. The
plasma was stored in aliquots at –80°C until assayed for
cytokines. To one of the two remaining tubes, 50 µL LPS
(E.coli serotype 055:B5; Sigma, St Louis, USA; final
concentration 10 µg/mL) were added to stimulate cytokine
production. Unstimulated samples contained aprotinin,
but no LPS. Both tubes were incubated at 37°C for
24 hours, and thereafter centrifuged; the supernantants
were stored at – 80°C, until assayed for cytokines.
To collect appropriately timed specimens for serological
assay (equal to or more than day 6 after onset of fever)
[15-18], 2 ml of blood were collected on the day of admis-
sion and at discharge. Blood was centrifuged at 1000-
1500 rpm for 10 minutes, then, serum was transferred to
screw cap Eppendorf tubes and stored at – 80°C until
assayed. For the transport from Indonesia to The Nether-
lands, the samples for cytokine and serological assays
were kept on dry ice.
Cytokine assays
TNF-a, IL-1b and IL-1Ra were measured in duplicate by
nonequilibrium radioimmunoassay (RIA) [19]. Recombi-
nant human TNF-a, IL-1b and IL-1Ra were calibrated
against standards provided by the National Institute of
Biological Standards and Control (Potters Bar, UK), with
the sensitivity of the assay with 100 µl sample, of
40 pg/ml, 40 pg/ml, and 80 pg/ml, respectively. IFN-c and
IL6 were measured with ELISAs obtained from the Cen-
tral Laboratory of the Netherlands Red Cross Blood Trans-
fusion Service,Amsterdam, The Netherlands, according to
manufacturer’s instruction. Levels of IFN-c exceeding
40 pg/ml and levels of IL6 exceeding 10 pg/ml were con-
sidered to be elevated.
Serology
In all cases, the diagnosis of dengue infection was con-
firmed by serological assays. We used a capture and indi-
rect enzyme-linked immunosorbent assay (ELISA) detect-
ing dengue specific IgM and IgG antibodies in serum
samples, according to a previously described procedure
[20].
Statistical analysis
Continuous data were described as mean (SD), and me-
dian; whereas nominal data were described as numbers.
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Two-tailed t-tests were done to compare numerical vari-
ables between survivors and non-survivors. The assump-
tion of normality of the data was checked before the t-test.
Mann-Whitney U tests were done when the data were not
normally distributed. The cut-off-point of significance was
p = 0.05 with a 95% confidence interval. Logistical regres-
sion analysis was done to calculate the association be-
tween cytokines and mortality.All statistical analyses were
performed using SPSS for Windows, version 9.0.
RESULTS
Between June and November 1996, 50 children with a
clinical diagnosis of DSS were enrolled in the study. Base-
line characteristics of the patients are listed in the table 1.
All children were admitted during the acute phase of the
disease. Symptoms had started 2-7 days (mean 4.2 ± 1)
before admission to the Intensive Care Unit. Thirteen
patients (26%) died during follow up. Death in these pa-
tients was due to shock and serious bleeding complica-
tions, and diffuse intravascular coagulation. The clinical
diagnosis was confirmed by serological assay in all pa-
tients, either by an IgM response or a fourfold rise in IgG
titres. Antibody profiles were typical for secondary dengue
infection.
Plasma concentrations of cytokines during the course
of the disease
In figure 1a, b the plasma concentrations of proinflamma-
tory cytokines TNF-a and IL-1b are depicted during the
course of the disease. The median values of these cytokines
do not change during the course of the disease. However,
(figure 1c) the plasma concentrations of the anti-
inflammatory cytokine IL-1Ra were considerably elevated
during the acute phase compared to recovery. Median
plasma concentrations of IFN-c and IL-6 were not el-
evated. In two patients who died, greatly elevated TNF-a
concentrations (both 2500 pg/ml) and IL-6 (86.000 and
199000 pg/ml) were found.
Ex vivo production of TNF-a, IL-1b and IL-1Ra
As shown in table 2, the ex vivo production of IL-1Ra after
incubation for 24 hours without LPS was higher during the
first days of admission than at recovery; the ex vivo pro-
duction of TNF-a and IL-1b did not change during the
course of illness. However, when stimulated with LPS, the
median ex vivo production of both TNF-a and IL-1b was
strongly depressed during the acute phase of the disease as
compared to the amounts produced at recovery. The latter
amounts are in the same order as those in normal individu-
als in the Netherlands. The IL-Ra production in the pres-
ence of LPS was slightly lower at admission than during
the subsequent days.
Plasma concentrations of cytokines on the day
of admission in survivors and non-survivors
The plasma concentrations of TNF-a, IL-1b and IFN-c on
the day of admission of survivors and non-survivors were
not significantly different (mean values ± SD in pg/ml, and
p value): TNF-a: 154.7 ± 54.0 versus 556.6 ± 909.3,
p = 0.254; IL-1b: 73.2 ± 21.5 versus 115.7 ± 91.6,
p = 0.089; IFN-c: 22.2 ± 7.8 versus 25.0 ± 11.8,
p = 0.376. However (figure 2), compared to survivors, the
mean plasma concentrations IL-1Ra were significantly
higher in non-survivors: 802.2 ± 566.4 versus
1566.9 ± 675.6, p = 0.0005. Also for IL-6, the mean
plasma concentrations were higher in non-survivors
Table 1
Characteristics of 50 patients with dengue shock syndrome
Age in years 6.6 ± 2.8 (3-13)
Days since onset of disease 4.2 ± 1 (2-7)
Male 24 (48%)
Female 26 (52%)
Clinical diagnosis (WHO criteria)
DHF III 43 (86%)
DHF IV 7 (14%)
Positive serology 50 (100%)
Number of deaths 13 (26%)
Age and days since onset of disease are mean ± SD (range)
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Figure 1a
Median plasma concentrations of tumor necrosis factor-a (pg/ml)
with 25 and 75 interquartile ranges, on the day of admission (D0):
155 (120 – 176.2); D1: 140 (120 – 167.5); D2: 150 (125 – 170) and
D7 or day of discharge: 135 (115 – 155).
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Figure 1b
Median plasma concentrations of interleukin-1b (pg/ml) with 25 and
75 interquartile ranges, on the day of admission (D0): 72.5 (60 – 90);
D1: 80 (60 – 101); D2: 80 (65 – 97.5) and D7 or day of discharge: 70
(57.5 – 92.5).
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compared to survivors (219.50 ± 58262.0 versus 172.1 ±
956.8, p = < 0.00001), but the median values of IL-6 in
both groups were 9.5 and 1.0 pg/ml, respectively.
Ex vivo production of TNF-a, IL-1b and IL-1Ra on
the day of admission in survivors and non-survivors
Table 3 shows the patterns of the proinflammatory cytok-
ines TNF-a and IL-1b and of the anti-inflammatory cytok-
ine IL-1Ra. The ex vivo production of IL-1Ra was signifi-
cantly higher in non-survivors than in survivors, both
without LPS stimulation (p = 0.0008) and with LPS (p <
0.004). The LPS-stimulated production of IL-1b was
lower in non-survivors than in survivors (516.1 ±
270.0 versus 2252.2 ± 4152.9 pg/ml), but this difference
did not reach statistical significance.
Association of plasma concentrations of cytokines
on the day of admission with mortality
We calculated the association of plasma concentrations of
TNF-a, IL-1b, IL-6, IFN-c and IL-1Ra on the day of
admission, with mortality. IL-1Ra was significantly asso-
ciated with mortality in these 50 children with DSS (Table
4).
Table 2
Median ex vivo production of cytokines after 24 hr incubation
with and without lipopolysaccharide in 50 children with den-
gue shock syndrome
Cytokine Day 0 Day 1 Day 2 Day 7/
discharge
pg/ml pg/ml pg/ml pg/ml
Without LPS
TNF-a 345 365 330 330
IL-1b 65 80 80 72.5
IL-1Ra 240 2700 3100 1400
With LPS
TNF-a 520 510 590 3850
IL-1b 660 755 1320 9450
IL-1Ra 6975 8750 9850 10500
LPS: lipopolysaccharide
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Figure 2
Plasma concentrations of interleukin-1 receptor antagonist on the day of admission (D0) in survivors and non-survivors of 50 patients with
dengue shock syndrome. The difference is significant (p < 0.0005). Normal value 139 pg/ml (range < 80-502).
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Figure 1c
Median plasma concentrations of interleukin-1 receptor antagonist
(pg/ml) with 25 and 75 interquartile ranges, on the day of admission
(D0): 795 (505 – 1437.5); D1: 555 (355 – 775); D2: 590 (387.5 –
980) and D7 or day of discharge: 395 (330 –565).
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DISCUSSION
In 50 children admitted with proven DSS, we found that
plasma concentrations of IL-1Ra were considerably el-
evated and that high concentrations of this antiinflamma-
tory cytokine correlated with mortality.
It is generally assumed that high concentrations of antiin-
flammatory cytokines in the circulation reflect proinflam-
matory cytokine production in the tissues. Also, compared
to an anti-inflammatory cytokine like IL-1Ra, the proin-
flammatory cytokine responses are relatively short-lived in
serious infections, and elevated concentrations in plasma
are only found shortly after onset [21]. Since our patients
with DSS were admitted a mean of 4.2 days after onset of
disease (table 1), this may explain why we have found only
slightly elevated median plasma concentrations of TNF-a
and IL-6, although greatly elevated TNF-a concentrations
and IL-6 were found in two patients, both of whom died.
Other investigators have reported high concentrations of
circulating TNF-a in dengue, correlating with disease ac-
tivity [6, 7]. We could not confirm these data. One reason
for this discrepancy may be the timing of blood sampling.
In our study, the earliest samples in which cytokines were
measured, were collected 4 (median) days (range 2-7) after
onset of disease. Therefore, we may have missed possible
high concentrations of IL-6 and TNF-a during the first
days of infection. From a previous study of mild dengue,
we know however that cytokines are not elevated in that
situation (unpublished). In addition, the development from
mild dengue to DSS often occurs abruptly, making admis-
sion urgent. In view of these observations, it is remarkable
that the concentrations of cytokines are not found to be
more elevated.An additional explanation may be the use of
a different TNF-a assay. However, the fact that we also
found low median IL-6 concentrations gives support to our
TNF-a data, since IL-6 is induced mainly by TNF-a, and is
a very sensitive marker for activation of the cytokine
network. In comparison with other critical illnesses such as
septic shock, it is remarkable that IL-6 concentrations nor-
malize relatively soon in dengue, even when patients are
(still) critically ill. These findings on IL-6 are very similar
to those found in a study elsewhere in Indonesia, i.e., in
Yogyakarta [22].
We did not find evidence for production of the type I
cytokine IFN-c in DSS. Other investigators have observed
that IFN-c levels were increased, decreasing abruptly one
day after defervescence [13], coinciding with the disap-
pearance of viraemia [23]. Therefore, as for TNF-a and
IL-6, we may have missed the IFN-c peak due to relatively
late sampling.
Our results indicating that IL-RA is a marker of severity
are somehow in agreement with those of Pinto et al. [9],
who found elevated IL-1Ra concentrations in five out of
31 patients with mild dengue.
In the acute phase of the disease, the ex vivo production of
TNF-a and IL-1b after incubation with LPS was consider-
ably depressed but returned to normal on recovery. Such
low production capacity of proinflammatory cytokines has
been found in severe bacterial infections such as sepsis
[24, 25], typhoid fever [26], and acute meningococcal
disease [27], and apparently also occurs in this severe viral
infection. The degree of down-regulation of proinflamma-
tory cytokine production has been shown to correlate with
disease severity in the bacterial infections mentioned and
seems to mirror the magnitude of the initial systemic
cytokine response. In our patients, the degree of down-
regulation of proinflammatory cytokines did not signifi-
cantly differ between survivors and non-survivors. The
up-regulation of the anti-inflammatory cytokine IL-1Ra,
however, was significantly more pronounced in non-
survivors.. The down-regulation of cytokine production
may be a result of action of the anti-inflammatory cytokine
IL-10, which has been shown to be elevated in dengue by
other investigators [7, 28, 29]. This cytokine has been
implicated in the shift to a type 2 cytokine response in
severe dengue [30].
It is remarkable that in all children suspected of suffering
from DSS the diagnosis was right. Apparently, in an en-
demic area during an outbreak, experienced clinicians
recognize the rather specific clinical picture of DSS. In
adults, the diagnosis is more difficult; this became clear
from a prospective study we performed in Semarang, in
which 51% of patients with suspected dengue were, in fact,
suffering from other diseases. In 20 of the patients without
dengue, proof for other infections agents was obtained
(influenza A, chikungunya, rubella, hantavirus, Lep-
tospira, Rickettsia spp).
We conclude that in hospitalized children with DSS (DHF
III and DHF IV), IL-1Ra is a valid prognostic marker, since
it is associated with mortality, and because of its relatively
long half life, it can be reliably measured. Its presence
provides indirect evidence for preceding proinflammatory
cytokine activity, such as of IL-1b. The transient proin-
flammatory cytokine patterns in the blood, with the pro-
nounced antiinflammatory response observed, lend little
Table 4
Multiple logistic regression analysis of plasma cytokines on
day of admission and mortality
Cytokine b p-value
TNF-a (per 10pg/ml) – 0.125 0.275
IL-1b (per 10pg/ml) 0.203 0.377
IL-6 (per 1000pg/ml) 0.203 0.734
IFN-c (pg/ml) – 0.290 0.887
IL-1Ra (100pg/ml) 0.266 0.007
Constant 2.403 0.953
b: regression coefficient. IL-1Ra is significantly associated with mortality, the
predicted value changes by 0.26 each time IL-1Ra increases 100 pg/ml.
Table 3
Ex vivo production of cytokines after 24 hr incubation with or
without lipopolysaccharide on day of admission in survivors
and non-survivors
Cytokine Survivors
(n = 37)
Non-survivors
(n = 13)
p valuea
pg/ml pg/ml
Without LPSb
TNF-a 362.5 ± 219.2 1748.0 ± 3356.1 0.107
IL-1b 76.8 ± 38.9 86.9 ± 49.3 0.584
IL-1Ra 2506.9 ± 2388.9 6823.0 ± 5435.5 0.0008
With LPS
TNF-a 714.2 ± 791.7 1622.3 ± 2946.7 0.719
IL-1b 2252.2 ± 4152.9 516.1 ± 270.0 0.084
IL-1Ra 7141.4 ± 3436.5 11750.0 ± 5473.9 < 0.004
Values are mean ± SD; aMann-Whitney U-test.
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support for anti-cytokine strategies in DSS when patients
have already been ill for 3-4 days.
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